The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples